Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Besunyen Detox Tea (also known as Besunyen Changrun Tea) is a proprietary herbal blend developed by Besunyen Holdings, a leading provider of therapeutic teas in China. The product is primarily marketed for the treatment of chronic constipation and the promotion of gastrointestinal health. Its formulation includes a variety of traditional Chinese medicinal herbs, most notably Senna leaf (*Cassia angustifolia*) and Cassia seed (*Cassia obtusifolia*), which contain anthraquinone derivatives such as sennosides. These compounds act as stimulant laxatives by increasing the permeability of the colonic mucosa and stimulating peristaltic contractions of the large intestine. Other ingredients like Hawthorn and Green tea are included to support digestion. The product is regulated as a health food in China and has been the subject of post-marketing clinical trials to evaluate its efficacy and safety in patients with functional constipation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Besunyen Detox Tea.